This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Anemia, Iron-Deficiency, Puerperal Disorders or Depression, Postpartum
and you are
between 18 and 45
years old
This is an advanced phase trial assessing
the effectiveness of the new treatment before being released on the market.
Show me locations

The purpose

200 patients with post partum anemia will be randomised to receive either intravenous iron (intervention group) or peroral iron (control group). The hypothesis is that intravenous iron supplementation is superior to standard peroral iron.

Provided treatments

  • Drug: Ferric carboxymaltose
  • Drug: Ferrous sulfate tablets
Tris trial is registered with FDA with number: NCT00929409. The sponsor of the trial is Norwegian University of Science and Technology and it is looking for 30 volunteers for the current phase.
Official trial title:
A 6-week Randomised, Open Comparative, Multi-centre Study of Intravenous Ferric Carboxymaltose (Ferinject) and Oral Iron (Duroferon) for Treatment of Post Partum Anemia